• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 40 of 100
INV.03.20.Immunotherapy-Drugs
Magazine
‘Miracle’ cancer treatments could be a blessing for investors too
By Ryan DerousseauFebruary 13, 2020
generic drug shot gene therapy
Commentary
How this gene therapy drug earned its $2.1 million price tag
By Sally C. PipesFebruary 7, 2020
CRISPR Gene Editing Trial Cancer Safety
Newsletters
First step in study shows CRISPR gene-edited cells are safe for use in cancer patients
By Sy MukherjeeFebruary 6, 2020
Workers protective suits prepare surgical masks at a factory in China during the Wuhan coronavirus outbreak.
Tech
Startup uses A.I. to identify molecules that could fight coronavirus
By Jeremy KahnFebruary 6, 2020
Nestle Aimmune Peanut Allergy Drug
Newsletters
Nestlé invests another $200 million in Aimmune’s peanut allergy drug
By Sy MukherjeeFebruary 5, 2020
A Walgreens employee was criminally charged with impersonating a pharmacist and illegally filling more than 745,000 prescriptions in the San Francisco Bay Area.
Health
Walgreens will pay $7.5 million over phony pharmacist who filled 750,000 prescriptions
By The Associated PressFebruary 4, 2020
A vaccine that looked promising for HIV doesn’t work
Newsletters
A vaccine that looked promising for HIV doesn’t work
By Sy MukherjeeFebruary 3, 2020
Coronavirus vaccine development
Health
The first coronavirus drug candidate is set for testing in China
By Sy MukherjeeFebruary 3, 2020
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
Health
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
By Sy MukherjeeFebruary 2, 2020
Vertex Pharmaceuticals Earnings 2019
Newsletters
Vertex CEO takes an earnings victory lap right before he exits
By Sy MukherjeeJanuary 31, 2020
Eli Lilly Earnings Diabetes Sales
Newsletters
Eli Lilly smashed Wall Street projections thanks to its diabetes drugs
By Sy MukherjeeJanuary 30, 2020
Michael Bloomberg Drug Pricing Patents
Health
Michael Bloomberg’s radical plan to cut prescription drug costs
By Sy MukherjeeJanuary 28, 2020
Former Turing Pharmaceuticals CEO Martin Shkreli Jury To Start Deliberations In Fraud Trial
Health
‘Pharma bro’ Martin Shkreli sued for alleged violation of antitrust law
By Erik Larson, Riley Griffin and BloombergJanuary 27, 2020
China Coronavirus Vaccine
Newsletters
The hunt for a coronavirus vaccine begins
By Sy MukherjeeJanuary 24, 2020
Civica Rx Blue Cross Generic Drug Prices
Health
Major insurers are teaming up with a nonprofit to cut the price of generic drugs
By Sy MukherjeeJanuary 23, 2020
1...
  • 38
  • 39
  • 40
  • 41
  • 42
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Economy
Elon Musk’s DOGE swiped $329 million in humanitarian funding from Nepal, leaving a Gen Z tech revolution to transform the budding country’s economyplaceholder alt text
By Sasha RogelbergSeptember 20, 2026
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.